Tatva Chintan Board Meeting on May 16, 2026 to Consider Results
Tatva Chintan Pharma Chem Ltd has scheduled a Board of Directors meeting on May 16, 2026, to consider and approve the standalone and consolidated audited financial results for the quarter and financial year ended March 31, 2026. The board will also consider recommending a final dividend for FY26, subject to shareholder approval. The trading window for designated persons has been closed from April 1, 2026, until 48 hours after the financial results are made public.
Key Highlights
- Board meeting scheduled for May 16, 2026 to approve FY26 financial results.
- Consideration of final dividend for FY26 is on the agenda.
- Trading window closed from April 1, 2026, until 48 hours post results.
- Results to be available on the company website.
Price Impact
More from TATVA
More in Board Meeting
Sambhv Steel Tubes Board Meeting on July 15, 2026 to Consider Fund Raising
Vineet Laboratories Board Meeting on July 15, 2026 for Audited Results
LTM (ex-LTIMindtree) Q1 strong: consol PAT +17% YoY to ₹1,469 Cr, revenue +18%, margins expand